To date there has been no notices re the sale of the Oraline patents.I would have thought a competitor would snap these up just to take out any other competitor getting their hands on same.Greenday had previously invested in SBN and obviously thought that the drug testing business offered growth opportunities.I am just wondering if they still consider this to be the case and a looking around for a suitale partner in the drug testing business.When Greenday backdoored the scaffolding company using an eye company shell the eye company's patents were sold off very early in the process.
To date there has been no notices re the sale of the Oraline...
Add to My Watchlist
What is My Watchlist?